PCVX Sale Disclosure
Guggenhime Andrew · SEC Form 4 · Filed Jul 6, 2026
Sale
Calculated transaction value
$120.55K
Guggenhime Andrew President And CFO
PCVX
Vaxcyte
PCVX
Transaction date
Jul 6, 2026
Public filing date
Jul 6, 2026
Filing lag
Filed same day
PCVX daily price context
Close on/before transaction
$56.96
Jul 6, 2026
Close before public filing
$58.39
Jul 2, 2026
Return since public filing
+5.05%
Through Aug 20, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,087 shares @ $57.76
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001230724-26-000012
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$626.34K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vaxcyte, Inc. PCVX | Exercise | Jul 6, 2026 | $53.5K |
| Vaxcyte, Inc. PCVX | Sale | Jul 6, 2026 | $452.28K |
| Vaxcyte, Inc. PCVX Current | Sale | Jul 6, 2026 | $120.55K |
| Vaxcyte, Inc. PCVX | Exercise | Jul 6, 2026 | $0 |